A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

So, what's the tea on microdosing? It's pretty much what it sounds like — taking smaller doses than the usual prescribed ...

Kernel density plots also indicated good balance (online supplemental figure 1). Of the initiators, 635 (61.9%) started treatment with liraglutide, 231 (22.5%) semaglutide, 120 (11.7%) dulaglutide, 25 ...